Fig. 6
From: RepCOOL: computational drug repositioning via integrating heterogeneous biological networks
Structural relationship between the repurposed (highlighted by rectangles) and FDA-approved drugs for the treatment of breast cancer. a Heat map of the merged repurposed and FDA-approved drugs based on the distance matrix. b Heat map of repurposed and FDA-approved drugs based on the correlation matrix. c Cluster dendrogram of repurposed and FDA-approved drugs based on the distance matrix. The highest and the lowest structural correlation are indicated in blue and red, respectively